Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, will attend the conference and deliver two high-profile sessions—a panel discussion alongside top industry experts on "AI's Race to Reinvent Medicine", and a solo keynote address exploring "How to Address Diseases and Aging Simultaneously Using Frontier AI".

- A research team led by Professor Yong Man Ro from the School of Electrical Engineering addressed AI hallucinations caused by sensory misinterpretation.

- Successfully suppressed cross-modal hallucination, in which the AI fabricates sounds that do not actually exist based on visual cues.

- The technology can be applied without additional model training, paving the way for next-generation autonomous vehicles, robots, drones, and security screening systems.

What if cancer screening no longer had to look for one cancer at a time? Cancer screening has long followed a one-organ-at-a-time model: mammography for breast cancer, colonoscopy for colorectal cancer, low-dose CT for lung cancer, and cervical testing for cervical cancer. These programs save lives, but they also leave gaps. Many cancers still lack routine screening, while patients often face multiple appointments, tests, and follow-up procedures.

This article features a candid conversation with Prof Atul Bhargav, Founder of Cellegant Energy Systems Pvt Ltd, about transforming hydrogen fuel cell research into practical products, the challenges of building a deep-tech startup in India, and why engineering innovation must move beyond the laboratory.